The U-Shaped Relationship Between Eosinophil Count and Bronchiectasis Severity

医学 支气管扩张 嗜酸性粒细胞 嗜酸性 胃肠病学 嗜酸性粒细胞增多症 前瞻性队列研究 肺功能 肺功能测试 内科学 哮喘 病理 肺
作者
Miguel Ángel Martínez‐García,Raúl Méndez,Casilda Olveira,Rosa María Girón,Marta María García Clemente,Luís Máiz,Oriol Sibila,Rafael Golpe,Juan Luis Rodríguez Hermosa,Esther Barreiro,Concepciόn Prados,Juan Rodríguez-López,Grace Oscullo,Gonzalo Labarca T.,David de la Rosa
出处
期刊:Chest [Elsevier BV]
卷期号:164 (3): 606-613 被引量:65
标识
DOI:10.1016/j.chest.2023.04.029
摘要

Background Although a proven relationship exists between the blood eosinophil count (BEC) and the severity of both asthma and COPD, its relationship with bronchiectasis has not been well established. The objective of this study was to analyze the relationship between BEC and the number and severity of exacerbations, and patients' responses to inhaled corticosteroid (IC) treatment in bronchiectasis Research Question Does an association exist among BEC, the number of exacerbations and severity of bronchiectasis, and IC treatment? Study Design and Methods This was a multicenter (43 centers) prospective observational study derived from the Spanish Bronchiectasis Registry. Patients with proven bronchiectasis and a known BEC were included, whereas those with asthma or antieosinophilic treatments were excluded. Patients were divided into four groups according to the BEC at the time of inclusion in the study in a steady-state situation: (1) eosinopenic bronchiectasis (< 50 eosinophils/μL), (2) low number of eosinophils (51-100/μL), (3) normal number of eosinophils (101-300/μL), and (4) eosinophilic bronchiectasis (> 300 eosinophils/μL). Results Nine hundred twenty-eight patients finally were included: 123 patients (13.3%) with < 50 eosinophils/μL (eosinopenic group), 164 patients (17.7%) with 50-100 eosinophils/μL, 488 patients (52.6%) with 101-300 eosinophils/μL, and 153 patients (16.5%) with > 300 eosinophils/μL (eosinophilic group). BEC showed a significant U-shaped relationship with severity, exacerbations, lung function, microbiologic profile, and IC treatment (these being higher in the eosinopenic group compared with the eosinophilic group). IC treatment significantly decreased the number and severity of exacerbations only in the group of bronchiectasis patients with > 300 eosinophils/μL. Interpretation A significant U-shaped relationship was found between BEC and severity and exacerbations in bronchiectasis that was more pronounced in the eosinopenic group. IC treatment decreased the number and severity of exacerbations only in the eosinophilic group. Although a proven relationship exists between the blood eosinophil count (BEC) and the severity of both asthma and COPD, its relationship with bronchiectasis has not been well established. The objective of this study was to analyze the relationship between BEC and the number and severity of exacerbations, and patients' responses to inhaled corticosteroid (IC) treatment in bronchiectasis Does an association exist among BEC, the number of exacerbations and severity of bronchiectasis, and IC treatment? This was a multicenter (43 centers) prospective observational study derived from the Spanish Bronchiectasis Registry. Patients with proven bronchiectasis and a known BEC were included, whereas those with asthma or antieosinophilic treatments were excluded. Patients were divided into four groups according to the BEC at the time of inclusion in the study in a steady-state situation: (1) eosinopenic bronchiectasis (< 50 eosinophils/μL), (2) low number of eosinophils (51-100/μL), (3) normal number of eosinophils (101-300/μL), and (4) eosinophilic bronchiectasis (> 300 eosinophils/μL). Nine hundred twenty-eight patients finally were included: 123 patients (13.3%) with < 50 eosinophils/μL (eosinopenic group), 164 patients (17.7%) with 50-100 eosinophils/μL, 488 patients (52.6%) with 101-300 eosinophils/μL, and 153 patients (16.5%) with > 300 eosinophils/μL (eosinophilic group). BEC showed a significant U-shaped relationship with severity, exacerbations, lung function, microbiologic profile, and IC treatment (these being higher in the eosinopenic group compared with the eosinophilic group). IC treatment significantly decreased the number and severity of exacerbations only in the group of bronchiectasis patients with > 300 eosinophils/μL. A significant U-shaped relationship was found between BEC and severity and exacerbations in bronchiectasis that was more pronounced in the eosinopenic group. IC treatment decreased the number and severity of exacerbations only in the eosinophilic group.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
yyy完成签到,获得积分10
2秒前
lv完成签到,获得积分10
2秒前
3秒前
3秒前
圆圈完成签到,获得积分10
3秒前
Abracadabra的应助被wwwwwl采纳,获得10
4秒前
KK完成签到,获得积分10
5秒前
6秒前
代迪完成签到,获得积分10
6秒前
超级无敌的应助被lv采纳,获得10
7秒前
8秒前
8秒前
不喝水的鱼完成签到,获得积分10
9秒前
9秒前
FreedomThh完成签到,获得积分10
9秒前
哇啦发布了新的文献求助10
9秒前
沐木完成签到,获得积分10
11秒前
11秒前
研友_8WbVOZ完成签到,获得积分10
12秒前
pp完成签到,获得积分10
12秒前
XPR发布了新的文献求助10
12秒前
星辰大海的应助被阿白采纳,获得10
12秒前
ad完成签到,获得积分20
13秒前
zheng-homes发布了新的文献求助30
13秒前
是我呀吼发布了新的文献求助10
14秒前
充电宝的应助被XPR采纳,获得10
15秒前
CJJ完成签到,获得积分10
16秒前
王小玮完成签到,获得积分10
16秒前
平常的路人完成签到,获得积分10
17秒前
蜻淼完成签到 ,获得积分10
18秒前
九里完成签到 ,获得积分10
20秒前
Leekr完成签到 ,获得积分10
21秒前
21秒前
21秒前
22秒前
22秒前
22秒前
叮咚咚完成签到,获得积分10
24秒前
Yyymuaaaaaa完成签到 ,获得积分10
24秒前
李健的应助被云起采纳,获得10
24秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181767
求助须知:如何正确求助?哪些是违规求助? 9571480
关于积分的说明 21818225
捐赠科研通 7778030
什么是DOI,文献DOI怎么找? 3433524
关于科研通互助平台的介绍 2557696
邀请新用户注册赠送积分活动 2479598